07.45 – 08.45:

Breakfast

Session III. LIPOPROTEINS AND LIPID TRANSPORT
Chaired by Simon Pfisterer (Finland) and Knut Tomas Dalen (Norway)

08.45 – 09.10:

The ER:lysosome bridge and the saga of cholesterol transport
Emily Eden (UK)

09.10 – 09.15:

Discussion

09.15 – 09.30:

High lipoprotein(a) increases risk of peripheral arterial disease, abdominal aortic aneurysms, and major adverse limb events
Peter Engel Thomas (Denmark) - YIA

09.30 – 09.45:

Increasing insight in the VLDL secretory pathway; a role for small leucin-rich protein 1 (SMLR1)
Ankia Visser (The Netherlands) - YIA

09.45 – 10.00:

Effect of breastfeeding on lipid profile and cardiovascular risk markers in women with familial hypercholesterolemia: The FH-FEMINA study protocol
Marianne Klevmoen (Norway) - YIA

10.00 – 10.15:

Liver-targeted Angptl3 and Angptl4 silencing by antisense oligonucleotide treatment attenuates hyperlipidemia and atherosclerosis development in APOE*3-Leiden.CETP mice
Melanie Modder (The Netherlands) - YIA

10.15 – 11.15:

Poster Walk (Session III). Coffee and tea

11.15 – 11.40:

Pharmacogenetics of lipid-lowering drugs
Mikko Niemi (Finland)

11.40 – 11.45:

Discussion

11.45 – 12.00:

Lipid profile during the first year of life
Sofie Taageby Nielsen (Denmark) - YIA

12.00 – 12.15

Functional analysis of LDLR variants using automated systems to improve rare-variant association studies and risk assessment in hypercholesterolemia
Mohammad Majharul Islam (Finland) - YIA

12.15 – 12.30

ApoM and S1P – markers for incident heart failure and death in patients with chronic kidney disease?
Sarunja Vijayakumar (Denmark) - YIA

12.30 – 13.30

Lunch

Session IV. OTHER TOPICS
Chaired by Carolina Hagberg (Sweden) and Kirsten Holven (Norway)

13.30 – 13.55:

Of women and men: lipids during the life course
Jeanine Roeters van Lennep (The Netherlands)

13.55 – 14.00:

Discussion

14.00 – 14.15

Stimulation of the beta-2-adrenergic receptor activates human brown adipose tissue in vivo
Patrick Rensen (The Netherlands)

14.15 – 14.30

Proprotein Convertase Subtilisin/Kexin 6 is involved in lipid metabolism in liver  
Bianca Suur (Sweden) - YIA

14.30 – 14.45

New evidence of cardiovascular risk factors for Alzheimer's disease
Jiao Luo (Denmark) - YIA

14.45 – 15.00:

Purinergic crosstalk between adipocyte-macrophage promotes degeneration of thermogenic brown adipose tissue
Michelle Jaeckstein (Germany) - YIA

15.00 – 16.00:

Poster Walk (Session IV). Coffee and tea

16.00 – 16.25:

Novel mechanisms of adipocyte function and metabolism
Alexander Bartelt (Germany)

16.25 – 16.30:

Discussion

16.30 – 16.45:

Risks associated with use of statins and other lipid-modifying agents across pregnancy – a nationwide drug safety study in Norway in 2005-2018
Jacob Juel Christensen (Norway) - YIA

16.45 – 17.00:

The STEROL ELEMENT BINDING PROTEIN 1C (SREBP1c) is an immunometabolic checkpoint of regulatory T lymphocytes
Fabrizia Bonacina (Italy)

17.00 – 17.15

Genome-Wide Sleep-SNP interactions on lipid traits to identify biomolecular pathways underpinning sleep-associated lipid disturbances
Raymond Noordam (The Netherlands) - YIA

17.15 – 17.30

Health economic costs generated by an FH mutation
Kjetil Retterstøl (Norway)

17.30 – 17.35

Concluding remarks
Anne Langsted  (Denmark)

17.35 – 18.30:

Leisure time

18.30 – 19.00:

Cocktail

19.00 –

Banquet and dancing